查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840591

體外膜氧合（ECMO）市場按設備類型、組件類型、患者類型、應用和最終用戶分類－2025-2032年全球預測

Extracorporeal Membrane Oxygenation Machine Market by Device Type, Component Type, Patient Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，體外膜氧合市場規模將達到 8.4014 億美元，複合年成長率為 5.40%。

主要市場統計數據
基準年 2024 5.5119億美元
預計年份：2025年 5.7925億美元
預測年份：2032年 8.4014億美元
複合年成長率 (%) 5.40%

權威機構對體外氧氣療法）作為一種成熟的高級支持方式的認知，再形成重症加護路徑和採購重點。

體外膜氧合（ECMO）已逐漸被臨床接受，設備工程的不斷改進使其從一種小眾的搶救療法轉變為高級重症加護監護中不可或缺的選擇。臨床醫生現在將體外支持視為一種過渡療法，可以在患者經歷急性呼吸或心臟危機時穩定其病情，同時尋求根治性治療或器官移植。因此，醫療系統和臨床團隊正在調整通訊協定，組成多學科ECMO團隊，並增加對訓練和模擬的投入，以確保安全地部署和撤機。

隨著技術創新者降低了設備複雜性並提高了迴路的生物相容性，體外膜氧合（ECMO）在傳統加護病房之外的應用潛力日益增強。同時，監管審查和報銷機制的動態既限制了ECMO的廣泛應用，也帶來了機會。因此，採購、臨床指導和設備製造等相關人員在重新調整優先事項，以平衡臨床療效、運作準備和採購靈活性。 ECMO的廣泛應用使其成為快速成熟的臨床選擇，對治療路徑、供應商關係和醫院資源規劃都有重大影響。

技術創新、營運模式重組和區域化醫療網路如何改變體外治療的提供方式和醫護人員關係

除了設備升級之外，體外膜氧氣療法（ECMO）領域正受到多項因素的共同再形成，這些因素正在重塑臨床工作流程、供應鏈和服務模式。幫浦技術、呼吸器效率和表面塗層的進步正在減少溶血和血栓併發症，從而實現更持久、更安全的治療。同時，雙腔插管策略和經皮途徑的興起正在縮短部署時間並提高支援的便攜性，從而能夠在急救現場或轉運過程中更快地啟動治療。

在營運方面，醫院正將體外膜氧合（ECMO）納入心胸外科和肺科診療流程，並加強常規訓練和模擬，以確保醫護人員能夠應對體外心肺復甦術的各種情況。遠端醫療和遠端監測工具正將專家監測擴展到規模較小的醫療中心，從而更有效地利用區域支援網路和集中式專家資源。在商業方面，製造商正在整合數位化診斷、即插即用的拋棄式以及強調執行時間和生命週期管理的售後服務合約。總而言之，這些變革性因素正推動ECMO在臨床應用方面取得進步，降低手術風險，並使設備性能與操作流程更加緊密地結合。

由於2025年關稅調整，體外循環系統供應鏈的韌性和採購彈性受到挑戰，這迫使企業重新評估籌資策略和零件在地化方案。

2025年美國關稅調整為體外膜氧合（ECMO）系統的設備採購、零件採購和供應鏈彈性帶來了新的動態。部分醫療零件和子組件的進口關稅凸顯了籌資策略的重要性，促使設備製造商和醫院重新評估其供應商佈局、零件本地化和庫存政策。為此，一些製造商加快了對替代供應商的資格認證，並建立了多元化的物流管道，以降低對單一國家採購的依賴。

關稅帶來的成本壓力促使人們更加關注供應鏈韌性的設計，包括模組化系統結構，這種架構允許在不影響臨床性能的前提下，用本地可用的組件進行替換。醫療系統正日益重視資本採購、耗材和服務合約的總落地成本，並考慮簽訂多年期合約以穩定價格和供應。此外，關稅促使製造商和監管機構展開對話，鼓勵盡可能加快國內生產核准核准，並強化在區域中心策略性儲備關鍵耗材的必要性。最終，2025年的關稅環境凸顯了採購彈性以及臨床、監管和供應鏈各部門密切合作的必要性。

深入分析揭示了設備類型、組件特性、患者群體、臨床應用和最終用戶環境如何影響策略重點。

市場區隔分析揭示了不同設備類型、組件、患者群體、臨床應用和終端用戶環境之間的差異化動態，這些差異共同指導產品策略和市場推廣策略。依設備類型分類，此細分市場可分為兩類：一類是針對心臟支持的靜脈-動脈系統，另一類是針對呼吸支持和體外氧合客製化的靜脈-靜脈系統。按組件類型分類，該生態系統由插管、控制器、熱交換器、氧合器和泵浦組成，每種組件都面臨各自獨特的工程挑戰和售後市場考量。依患者類型分類，成人、嬰幼兒和兒童患者的臨床需求各不相同，因此需要針對不同尺寸的插管技術、流量曲線和監測功能。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 整合人工智慧演算法進行即時體外膜氧合（ECMO）迴路參數最佳化
  • 可攜式、便攜性膜氧合（ECMO）系統的出現，使得在現場進行挽救生命的干涉成為可能。
  • 開發生物相容性聚合物塗層以減輕長期體外膜氧合（ECMO）支持應用中的血栓症
  • 擴大靜脈-動脈體外膜氧合（VA-ECMO）和移動式體外膜氧合（ECMO）團隊在成人心源性休克治療的應用
  • 低阻力中空纖維氧合器在改善新生兒和兒童體外膜氧合（ECMO）療效方面的進展
  • 監管部門的核准加速了微型體外生命支持設備在門診環境中的應用。
  • 醫療設備和軟體公司合作開發整合式體外膜氧合（ECMO）數位監測平台

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

8. 體外膜氧合市場（依設備類型分類）

  • VA
  • VV

9. 體外膜氧合市場（依組件類型分類）

  • 套管
  • 控制器
  • 熱交換器
  • 氧合設備
  • 泵浦

第10章 依病患類型分類的體外膜氧合市場

  • 成人
  • 嬰兒
  • 孩子們

第11章 體外膜氧合市場（依應用領域分類）

  • 心臟支持
    • 心源性休克
    • 心臟直視手術後
  • 體外心肺復甦
  • 呼吸支持

第12章 體外膜氧合市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
  • 專科診所

第13章 體外膜氧合市場區域分析

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 體外膜氧合市場（依組別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國體外膜氧合市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Getinge AB
    • Medtronic plc
    • LivaNova PLC
    • Terumo Corporation
    • Fresenius Medical Care
    • Hemovent NV
    • Spectrum Medical (UK) Limited
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Abiomed, Inc.
    • Abbott Laboratories
    • MicroPort Scientific Corporation
    • Nipro Corporation
    • OriGen Biomedical, Inc.
    • CytoSorbents Corporation
    • Senko Medical Instrument Mfg. Co., Ltd.
    • Braile Biomedica
    • Spectrum Medical Ltd.
    • Inspira Technologies OXY BHN Ltd.
    • Eurosets Srl
Product Code: MRR-03607F65CC95

The Extracorporeal Membrane Oxygenation Machine Market is projected to grow by USD 840.14 million at a CAGR of 5.40% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 551.19 million
Estimated Year [2025] USD 579.25 million
Forecast Year [2032] USD 840.14 million
CAGR (%) 5.40%

An authoritative orientation to extracorporeal membrane oxygenation as an established advanced support modality reshaping critical care pathways and procurement priorities

Extracorporeal membrane oxygenation has transitioned from a niche salvage therapy to an integral option within advanced critical care pathways, driven by incremental clinical acceptance and steady improvements in device engineering. Clinicians now view extracorporeal support as a bridge therapy that can stabilize patients through acute respiratory or cardiac crises while definitive therapies or organ recovery are pursued. Consequently, health systems and clinical teams are adapting protocols, assembling multidisciplinary ECMO teams, and investing in training and simulation to ensure safe deployment and weaning.

Technology innovators have reduced device complexity and improved circuit biocompatibility, which has increased the feasibility of deployment outside of traditional intensive care units. At the same time, regulatory scrutiny and reimbursement dynamics create both constraints and opportunities for wider adoption. As a result, stakeholders across procurement, clinical leadership, and device manufacturing are recalibrating priorities to balance clinical efficacy, operational readiness, and procurement flexibility. This introduction frames ECMO as a rapidly maturing clinical option with significant implications for care pathways, supplier relationships, and hospital resource planning.

How technological innovation combined with operational redesign and regionalized care networks is transforming extracorporeal therapy delivery and supplier relationships

The landscape for extracorporeal membrane oxygenation is being reshaped by several converging shifts that extend beyond device upgrades to influence clinical workflows, supply chains, and service models. Advances in pump technology, oxygenator efficiency, and surface coatings have reduced hemolysis and thrombotic complications, enabling longer and safer runs. Concurrently, the rise of dual-lumen cannulation strategies and percutaneous approaches has shortened deployment times and increased the portability of support, allowing for more rapid initiation in emergency and retrieval settings.

Operationally, hospitals are embedding ECMO into cardiothoracic and pulmonary care pathways, increasing routine training and simulation to ensure readiness for extracorporeal cardiopulmonary resuscitation scenarios. Telemedicine and remote monitoring tools are extending specialist oversight to smaller centers, enabling regionalized support networks and more efficient utilization of centralized expertise. On the commercial side, manufacturers are integrating digital diagnostics, plug-and-play disposables, and service contracts that emphasize uptime and lifecycle management. Taken together, these transformative forces are pushing ECMO toward greater clinical accessibility, lower procedural risk, and tighter alignment between device performance and operational workflows.

Supply chain resilience and procurement agility arising from tariff shifts in 2025 that forced reevaluation of sourcing strategies and component localization for extracorporeal systems

United States tariff changes in 2025 have introduced new dynamics for device sourcing, component procurement, and supply-chain resilience for extracorporeal membrane oxygenation systems. Import duties on select medical components and subassemblies have elevated the importance of procurement strategy, prompting device manufacturers and hospitals to reevaluate supplier footprints, component localization, and inventory policies. In response, some manufacturers accelerated qualification of alternative suppliers and secured diversified logistics channels to mitigate exposure to single-country sourcing.

These tariff-induced cost pressures encouraged a parallel emphasis on design for supply chain resilience, including modular system architectures that allow substitution of locally available components without altering clinical performance. Health systems assessed total landed cost across capital acquisition, consumables, and service contracts and increasingly considered multi-year agreements to stabilize pricing and availability. Furthermore, the tariffs stimulated dialogue between manufacturers and regulatory bodies to expedite domestic production approvals where feasible, and they reinforced the case for strategic stockpiles of critical disposables in regional centers of excellence. Ultimately, the 2025 tariff environment emphasized the need for agility in procurement and close collaboration across the clinical, regulatory, and supply-chain functions.

Segmentation-driven insights revealing how device type, component specialization, patient cohorts, clinical applications, and end-user settings shape strategic priorities

Segmentation analysis reveals differentiated dynamics across device types, components, patient cohorts, clinical applications, and end-user settings that collectively inform product strategy and go-to-market approaches. Based on device type, the field delineates between Veno Arterial systems optimized for cardiac support and Veno Venous systems tailored to respiratory support and extracorporeal oxygenation. Based on component type, the ecosystem comprises cannula, controllers, heat exchangers, oxygenators, and pumps, each carrying distinct engineering challenges and aftermarket considerations. Based on patient type, clinical requirements diverge among adults, infants, and pediatric patients, necessitating size-specific cannulation techniques, flow profiles, and monitoring capabilities.

Based on application, clinical deployment spans cardiac support, extracorporeal cardiopulmonary resuscitation, and respiratory support, with cardiac support further subdividing into cardiogenic shock and post cardiotomy interventions that demand rapid initiation and hemodynamic precision. Based on end user, adoption patterns vary across ambulatory surgical centers, hospitals, and specialty clinics, with hospitals remaining the primary locus for high-acuity cases while specialty clinics and select ambulatory settings expand capabilities for pre- and post-procedural care. Understanding these segmentation axes clarifies product development priorities, clinical training needs, and differentiated service models that manufacturers and providers must tailor to optimize both clinical outcomes and operational efficiency.

Regional strategic contrasts and collaborative opportunities that explain adoption patterns, regulatory influences, and supply choices across major global healthcare regions

Regional dynamics shape clinical adoption, regulatory pathways, and supply-chain choices across the Americas, Europe, Middle East & Africa, and Asia-Pacific, creating distinct strategic landscapes for stakeholders. In the Americas, established tertiary centers and integrated health systems have expanded extracorporeal programs, emphasizing protocol standardization, centralized training, and cross-institutional retrieval services. Reimbursement frameworks and regional centers of excellence have supported concentrated high-acuity capability while driving discussions about equitable geographic access and capacity building in smaller markets.

In Europe, Middle East & Africa, regulatory harmonization efforts and national procurement practices influence adoption cadence, with leading academic hospitals driving clinical guidelines and smaller health systems exploring partnerships or regional hubs. Training programs and mobile retrieval teams are important enablers in geographically dispersed regions. In the Asia-Pacific, rapid hospital expansion, growing critical care capacity, and targeted investments in advanced therapies have accelerated interest in extracorporeal systems, though variability in regulatory timelines and local manufacturing capabilities affects how global suppliers structure commercial entry and aftermarket support. Across all regions, cross-border collaboration on clinical registries and outcome benchmarks is increasingly shaping best practices and supplier selection criteria.

How integrated system providers and component specialists are competing on clinical performance, aftermarket service, and digital-enabled support to win long-term partnerships

Competitive dynamics among established manufacturers and specialized component suppliers are defined by a race to combine clinical performance with service excellence, consumable availability, and digital connectivity. Established system providers focus on delivering integrated platforms that minimize setup time, reduce complication risk, and offer predictable lifecycle costs through bundled service agreements. Component specialists concentrate on innovations in cannula design, oxygenator efficiency, and pump mechanics to offer performance advantages that can be licensed or incorporated into broader systems.

Across the value chain, aftermarket service and training have become differentiators, with suppliers offering simulation-based programs, remote diagnostics, and rapid-response field service to maintain clinical readiness. Partnerships between device makers and hospital networks are increasingly common, facilitating co-development of protocols, registry participation, and joint training curricula. Regulatory approvals and post-market surveillance activities favor manufacturers that maintain transparent quality systems and demonstrate sustained clinical outcomes. As capital cycles tighten, procurement teams weigh not only device performance but also supplier stability, spare-parts logistics, and the ability to support regional training and clinical governance.

Actionable strategic playbook for manufacturers and providers to strengthen design modularity, clinical training, supply resilience, and digital services for extracorporeal systems

Industry leaders should adopt a coordinated strategy that aligns product design, clinical engagement, and supply-chain resilience to capitalize on the maturation of extracorporeal therapies. Prioritize modular architectures that enable rapid substitution of components and facilitate upgrades without requiring full system replacement, thereby lowering total cost of ownership and improving procurement flexibility. Invest in clinical education programs and simulation centers to shorten the learning curve for new teams and to standardize protocols that reduce variability in outcomes.

Strengthen supplier diversification and nearshoring where feasible to mitigate tariff and logistics risk while negotiating multi-year consumable agreements to improve predictability for health systems. Expand digital capabilities to provide remote monitoring, predictive maintenance, and analytics that materially reduce downtime and support outcome benchmarking. Finally, cultivate transparent partnerships with leading clinical centers to generate real-world evidence and inform guideline development, which in turn will support broader adoption and reimbursement negotiations. These actions, carried out in parallel, will position companies and providers to deliver reliable extracorporeal care at scale while containing risk and demonstrating sustained clinical value.

A transparent, multi-source research approach combining clinician interviews, supplier engagement, regulatory review, and technical assessments to validate practical insights

This research integrates primary engagement with clinical and supply-chain stakeholders and a structured review of regulatory and technical literature to ensure an evidence-based perspective. Primary inputs included interviews with intensivists, cardiothoracic surgeons, perfusionists, procurement leaders, and senior device engineers to capture clinical practice variability, device performance expectations, and procurement constraints. Supplier discussions focused on manufacturing localization, component sourcing strategies, and aftermarket service models. Secondary sources encompassed peer-reviewed clinical studies, device labeling and regulatory filings, technical whitepapers, and publicly available hospital procurement guidelines to triangulate clinical outcomes and device feature sets.

Analytical techniques combined thematic synthesis of qualitative interviews with supply-chain mapping and technology readiness assessments to identify risk nodes and adoption enablers. Limitations include variability in institutional practice patterns and evolving regulatory decisions that can alter adoption timelines. Where possible, findings were validated across multiple stakeholder types to reduce single-source bias. The methodology emphasizes transparency and traceability so that decision-makers can align the research insights with their internal data and operational realities.

Integrated outlook on extracorporeal therapies emphasizing systems-level planning, clinician training, and supply resilience to sustain clinical impact

Extracorporeal membrane oxygenation has reached a strategic inflection point where technological maturity and clinical integration are converging to make it a practical element of modern critical care portfolios. Advances in device safety, coupled with operational innovations such as regionalized specialist networks and digital monitoring, have expanded clinical opportunities while exposing the importance of supply-chain resilience and targeted training. Stakeholders who proactively address procurement flexibility, service and training partnerships, and component localization will be best positioned to translate clinical possibility into reliable, repeatable outcomes across care settings.

Looking ahead, the most successful organizations will be those that treat extracorporeal therapy as a systems challenge rather than a single-device purchase, coupling product innovation with robust clinician education, lifecycle service offerings, and adaptive supply strategies. This integrated approach will be essential to sustain high-quality patient outcomes while managing capital and operational demands in an environment of evolving regulation and global trade dynamics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms for real-time ECMO circuit parameter optimization
  • 5.2. Emergence of portable and transportable ECMO systems enabling point-of-care lifesaving interventions
  • 5.3. Development of biocompatible polymer coatings to reduce thrombosis in prolonged ECMO support applications
  • 5.4. Expansion of venoarterial ECMO utilization in adult cardiogenic shock management and mobile ECMO teams
  • 5.5. Advancements in low-resistance hollow fiber oxygenators for improved neonatal and pediatric ECMO outcomes
  • 5.6. Regulatory approvals driving adoption of miniaturized extracorporeal life support devices in ambulatory care
  • 5.7. Collaborations between medical device and software firms for integrated ECMO digital monitoring platforms

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Extracorporeal Membrane Oxygenation Machine Market, by Device Type

  • 8.1. Veno Arterial
  • 8.2. Veno Venous

9. Extracorporeal Membrane Oxygenation Machine Market, by Component Type

  • 9.1. Cannula
  • 9.2. Controllers
  • 9.3. Heat Exchangers
  • 9.4. Oxygenators
  • 9.5. Pumps

10. Extracorporeal Membrane Oxygenation Machine Market, by Patient Type

  • 10.1. Adults
  • 10.2. Infants
  • 10.3. Pediatric

11. Extracorporeal Membrane Oxygenation Machine Market, by Application

  • 11.1. Cardiac Support
    • 11.1.1. Cardiogenic Shock
    • 11.1.2. Post Cardiotomy
  • 11.2. Extracorporeal Cardiopulmonary Resuscitation
  • 11.3. Respiratory Support

12. Extracorporeal Membrane Oxygenation Machine Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. Extracorporeal Membrane Oxygenation Machine Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Extracorporeal Membrane Oxygenation Machine Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Extracorporeal Membrane Oxygenation Machine Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Getinge AB
    • 16.3.2. Medtronic plc
    • 16.3.3. LivaNova PLC
    • 16.3.4. Terumo Corporation
    • 16.3.5. Fresenius Medical Care
    • 16.3.6. Hemovent N.V.
    • 16.3.7. Spectrum Medical (UK) Limited
    • 16.3.8. B. Braun Melsungen AG
    • 16.3.9. Baxter International Inc.
    • 16.3.10. Abiomed, Inc.
    • 16.3.11. Abbott Laboratories
    • 16.3.12. MicroPort Scientific Corporation
    • 16.3.13. Nipro Corporation
    • 16.3.14. OriGen Biomedical, Inc.
    • 16.3.15. CytoSorbents Corporation
    • 16.3.16. Senko Medical Instrument Mfg. Co., Ltd.
    • 16.3.17. Braile Biomedica
    • 16.3.18. Spectrum Medical Ltd.
    • 16.3.19. Inspira Technologies OXY B.H.N. Ltd.
    • 16.3.20. Eurosets S.r.l.

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO ARTERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO ARTERIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO ARTERIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO ARTERIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO ARTERIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO ARTERIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO VENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO VENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO VENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO VENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO VENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO VENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CONTROLLERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CONTROLLERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CONTROLLERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CONTROLLERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CONTROLLERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CONTROLLERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY INFANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY INFANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY INFANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY INFANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY INFANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY INFANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIOGENIC SHOCK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIOGENIC SHOCK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIOGENIC SHOCK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIOGENIC SHOCK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIOGENIC SHOCK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIOGENIC SHOCK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY POST CARDIOTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY POST CARDIOTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY POST CARDIOTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY POST CARDIOTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY POST CARDIOTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY POST CARDIOTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 266. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 267. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 20